Breaking News, Collaborations & Alliances

Scorpius Partners with Celltheon to Provide Cell Line Development Services

The first client signed under the partnership aims to scale up to GMP manufacturing.

Author Image

By: Charlie Sternberg

Associate Editor

Scorpius Holdings Inc., an integrated contract development and manufacturing organization (CDMO), has partnered with Celltheon Corporation to provide cell line development services to clients using Celltheon’s proprietary GOLDILOCKS transposase-based platform.   This collaboration enables clients to integrate with Scorpius’ program management team and quality system while preparing to transfer a research cell bank (RCB) to the Company’s facilities in San Antonio, TX, for further biomanufacturi...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters